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った。得られた各 A.linearis 抽出物について、MDCK 細胞（イヌ腎臓由来細胞株）
を使用した cell-based アッセイ系にて細胞毒性ならびに抗インフルエンザウイルス
活性を評価し、各抽出物について IC50（50%感染阻害濃度）、CC50（50%細胞障害濃





さらに、A.linearis 抽出物の作用機序を解析するため、time-of-addition assay を
おこなった。 
[結果] 
異なる抽出法により取得した A. linearis 抽出物についての抗インフルエンザウイ







Table 1: Anti-influenza A virus activity of Aspalathus linearis extracts  
Extraction 








Alkaline   1.6 ± 0.2    34.6 ± 8.0   21.9 
Ethanol  0.2 ± 0.1          1.3 ± 0.6     7 
Ethyl acetate   na
d
 >    10    na 
n-Hexane   na >    10    na 
Oseltamivir
e
 3.0 ± 0.0 >1000 >329 
 
aIC50 is 50% inhibitory concentration of extract. bCC50 is 50% cytotoxic concentration of extract. cSI 
is selectivity index which is the ratio of CC50 to IC50.dna is abbreviation of no activity. eOseltamivir 
unit is µM. All data are represented as mean ± standard error of mean of two independent 















(%)   SI
a
 IC50 (µM) SI 
Oseltamivir- 
Sensitive 
A/Nagasaki/HA-6/2009    CI
c
 0.3 ± 0.0  134.6   36 ± 28  51.4 
A/Nagasaki/HA-33/2009  CI 1.2 ± 0.6    32.4   39 ± 16  47.4 
A/PR/8/34                          LS
d
 0.5 ± 0.1  102.9    9.4 ± 0.9 190 
A/WSN/33                        LS 1.6 ± 0.2    21.9    2.5 ± 0.5 740 
B/Brisbane/60/2008            LS 3.2 ± 0.0    13.5   75 ± 48  24.7 
B/Okinawa/6/2014             CI 3.0 ± 1.2    16.7   33 ± 6.5  56.1 
B/Okinawa/8/2014             CI 4.7 ± 0.8    12.8   11  67.3 
B/Lee/40                            LS 3.1 ± 0.3    17.3   23 ± 3.5  80.4 
Oseltamivir- 
Resistant 
A/Nagasaki/HA-58/2009  CI 0.9 ± 0.0    43.8  870   2.1 
B/Okinawa/4/2014            CI 3.8 ± 0.7   12.4  970   1.9 
B/Okinawa/7/2014            CI 3.2 ± 0.5    14.5 >1000 < 1.8 
aSI was calculated as ratio of CC50 =34.6±8.0% which calculated by WST-1 assay, to each IC50 value; 
boseltamivir IC50 value 
and SI was taken from Charyasriwong et al., 2016; cCI is abbreviation of clinical isolate; dLS is abbreviation of Laboratory 





た (Table 3)。 
 
Table 3: Relative virus yield of time-of-addition assay  
 
Relative virus yield (%)a 
5% Alkaline extract 20 µM Oseltamivir 
During infection         100         100 
0-12  hpib         28 ± 17.7            2 ± 1.6*  
0-3   hpi       >100           49 ± 24  
3-6   hpi       >100         >100  
6-9   hpi         61 ± 21           51 ± 28  
9-12  hpi          7 ± 1.4*            1 ± 0.8*  
   aRelative virus yield was calculated as percentage ratio of treatment after infection to treatment during 
infection. bhpi is abbreviation of hours post infection. *The asterisks indicate the significant difference 





既報において、A. linearisのアルカリ抽出物は HIV-1に対して SI=61.7 の活性を示
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